Supernus Pharma's ADHD drug meets main goal in study on adolescents

Supernus Pharmaceuticals Inc said on Thursday its drug for attention deficit hyperactivity disorder met the main goal in a late-stage trial on adolescents, weeks after results from trials testing the drug on children failed to impress investors.

from Reuters: Health News https://ift.tt/2Cr2z8Z